News

Medscape15y
FDA approves first generic losartan formulations
Losartan tablets have been approved in 25-mg, 50-mg, and 100-mg doses, and losartan/hydrochlorothiazide combination tablets will be available in 50-mg/12.5-mg, 100-mg/12.5-mg, and 100-mg/25-mg ...
Miami Herald6y
Blood pressure medication recalled for impurity that might cause cancer
This covers lot No. JB8912 of Losartan Potassium Hydrochlorothiazide 100 mg or 25 mg tablets in 1,000-count bottles, expiration date 06/2020. None of the recalled tablets were distributed before ...
eturbonews3y
Losartan High Blood Pressure Medication Now Recalled
Mint Pharmaceuticals Inc. is recalling all lots of its prescription losartan ... HCTZ 50/12.5 mg TABLETS Mint Pharmaceuticals Inc. 02389657 2005011156 June 2023 MINT-LOSARTAN/HCTZ 100/12.5 mg ...
Business Insider6y
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine ...
The product can be identified as Losartan Potassium Hydrochlorothiazide, 100 mg/25 mg tablets in 1000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912; Exp. Date 06/2020. This product ...
Medscape5y
ARB Concerns Continue as Macleods Pulls Contaminated Losartan
Macleods Pharmaceuticals is recalling 32 lots of losartan potassium USP tablets and losartan potassium/hydrochlorothiazide (HCTZ) combination tablets after discovering trace amounts of the ...
Nature16y
Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy
Antihypertensive efficacy and safety of losartan/hydrochlorothiazide (HCTZ) combinations have not been adequately studied in Asians. In this open-label, 12-week study in seven Asian areas ...